Vector-Medica

Vector-Medica is a Russian biotechnology company based in the Koltsovo science city, specializing in the development and production of antiviral and immunomodulatory drugs. The company is a leader in liposomal technology, which it utilizes to enhance the delivery and efficacy of recombinant proteins, most notably interferons. Its flagship product, Lipint, represents a significant advancement as an oral liposomal interferon alpha-2b, providing a non-invasive alternative to traditional injectable therapies for hepatitis and other viral infections. Vector-Medica operates modern, GMP-certified manufacturing facilities and maintains a robust portfolio of products targeting infectious diseases and oncology. The company's origins are closely linked to the State Research Center of Virology and Biotechnology "Vector," one of the world's leading virology institutes.